Vir Biotechnology VIR
NASDAQ VIR
$10.61 -0.13 (-1.21%)
As of: Oct 21, 2026 · 3:05 PM EDT

Vir Biotechnology (VIR) Restructuring Costs (2023 - 2025)

Updated

Vir Biotechnology (VIR) recorded Restructuring Costs of -$182,000 in FY2025, compared with $35 million in FY2024.

Analysis

Vir Biotechnology (VIR) Restructuring Costs (2023 - 2025) Analysis & Trends

  • Per Business Quant data, VIR's Restructuring Costs was $35 million in FY2024 (+158.1%) and $13.56 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Vir Biotechnology 1.78 Bn -178.30 Mn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -172,000.00
Mar 31, 2025 -10,000.00
Dec 31, 2024 -3.94 Mn
Sep 30, 2024 12.71 Mn
Jun 30, 2024 26.28 Mn
Mar 31, 2024 -48,000.00
Dec 31, 2023 4.82 Mn
Sep 30, 2023 3.37 Mn
Jun 30, 2023 5.37 Mn
API Access

Vir Biotechnology Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VIR&period=max&api_key=YOUR_API_KEY